Sign in
4

Changes in Ownership

Neurogene Inc. Filed Acc 0001209191-22-044432

Options or other derivatives

  • President and CEO acquired 350,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

DRACHMAN JONATHAN G · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-08-02 Grant or award : show line 1 in the form Stock Option (Right to Buy) +350,000 350,000 D
Loading xslF345X03/doc4.xml…